Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M. Offer
Efficacy of Bortezomib in Systemic AL Amyloidosis With Relapsed/Refractory Clonal Disease
Haematologica
Hematology
Related publications
Safety and Efficacy of an Oncolytic Viral Strategy Using Bortezomib With ICE/R in Relapsed/Refractory HIV-positive Lymphomas
Blood advances
Hematology
Retreatment With Bendamustine-Bortezomib-Dexamethasone in a Patient With Relapsed/Refractory Multiple Myeloma
Case Reports in Hematology
Daratumumab, Bortezomib and Dexamethasone (Dvd) vs Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (Rrmm): Efficacy and Safety Update (Castor)
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficacy of Single-Agent Bortezomib vs. Single-Agent Thalidomide in Patients With Relapsed or Refractory Multiple Myeloma: A Systematic Comparison
European Journal of Haematology
Medicine
Hematology
Bortezomib Combination Therapy of Relapsed and Refractory Acute Lymphoblastic Leukemia in Children
Klinicheskaya Onkogematologiya/Clinical Oncohematology
Oncology
Hematology
Phase 2 Trial of Ixazomib in Patients With Relapsed Multiple Myeloma Not Refractory to Bortezomib
Blood Cancer Journal
Oncology
Hematology
Multicenter Phase II Study of Bortezomib in Patients With Relapsed or Refractory Mantle Cell Lymphoma
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Immunogenetic Characterization of Clonal Plasma Cells in Systemic Light-Chain Amyloidosis
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Treatment Patterns and Outcome Following Initial Relapse or Refractory Disease in Patients With Systemic Light Chain Amyloidosis
American Journal of Hematology
Hematology
